Dr. Amar U. Kishan, Assistant Professor, is the Vice-Chair of Clinical and Translational Research and Chief of the Genitourinary Oncology Service for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. Dr. Kishan graduated from the University of California, Berkeley with dual Bachelor of Arts degrees in Molecular and Cell Biology and Public Health. He earned his medical degree from Harvard Medical School, where he graduated magna cum laude from the joint Harvard-MIT Health Sciences and Technology Program. During medical school, he was awarded a Howard Hughes Medical Institute Fellowship to study tumor metabolism in the laboratory. He subsequently completed his internship training at Scripps Mercy Hospital in San Diego, where he was recognized as the H.H. Jones Intern of the Year. He then completed his residency training in radiation oncology at UCLA.
Dr. Kishan specializes in the utilization of radiation to treat genitourinary malignancies (particularly cancers of the prostate and bladder), as well as malignancies of the head and neck. He has an extensive research background and has published in leading journals such as JAMA, JAMA Oncology, European Urology, and Cancer Cell. He serves on several national committees and has received grant support from various national institutions, including the American Society of Radiation Oncology, the Radiological Society of North America, the Radiation Oncology Institute, and the Prostate Cancer Foundation.
Link to Dr. Kishan's PubMed publications >
Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results from a Multi-institutional Consortium Study
Advances in radiation technology help physicians deliver more precise and effective cancer treatment (UCLA Connect Blog)
Study reveals some types of prostate cancers may not be as aggressive as originally thought (UCLA Health) Men with low- and intermediate-risk prostate cancer can safely benefit from fewer, higher-dose radiation treatments ROI Announces the 2018 Publication Award Winner Finding ways to improve the survival for men with advanced prostate cancer Multiple-treatment approach improves survival rates in aggressive prostate cancer, study finds (UCLA Newsroom) High-dose radiation therapy as effective as surgery for aggressive prostate cancer (UCLA Health) Is There an Optimal Treatment for High-Risk Prostate Cancer? (jwatch.org) High-dose radiation therapy as effective as surgery for aggressive prostate cancer (UCLA Health) abc.net.au/radionational/programs/healthreport
Note: News website links may expire without notice.
Learn more about myUCLAhealth